← Back to Search

Thyroid lobectomy for Thyroid Cancer

Phase 2
Waitlist Available
Led By Linwah Yip, MD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial will use ThyroSeq to guide how much of the thyroid is removed during surgery for cancer. Data will be collected on how well this works.

Eligible Conditions
  • Thyroid Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of patients who require completion thyroidectomy for aggressive histology features
Secondary outcome measures
Number of patients who had central compartment neck dissection but no lymph node metastasis were identified
Number of patients with operative complications
QOL metric - FACT-G cumulative score preop, postop, and at followup
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Low RiskExperimental Treatment1 Intervention
Molecular testing and ultrasound features will be used to predict if thyroid cancer is low risk. Intervention will be to perform thyroid lobectomy.
Group II: High RiskExperimental Treatment1 Intervention
Molecular testing and ultrasound features will be used to predict if thyroid cancer is high risk. Intervention will be to perform more aggressive surgery to include total thyroidectomy with CCND.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Thyroid lobectomy
2017
Completed Phase 2
~100
Total thyroidectomy with CCND
2017
Completed Phase 2
~100

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,719 Previous Clinical Trials
16,342,241 Total Patients Enrolled
Linwah Yip, MDPrincipal Investigator - University of Pittsburgh
UPMC Bedford Memorial, UPMC Horizon-Greenville, UPMC Passavant-McCandless, UPMC Presbyterian, UPMC Shadyside, UPMC St. Margaret
University Of Chicago (Medical School)
Northwestern University Medical Sch (Residency)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still spots open for patients in this clinical trial?

"From the information available on clinicaltrials.gov, it seems that this study is looking for more participants as of right now. The original posting was on February 1st, 2017, with the most recent edit being on February 2nd, 2022."

Answered by AI

What percentage of patients experience complications from Thyroid lobectomy?

"While Phase 2 Thyroid lobectomy trials have some evidence supporting safety, there is currently no data to suggest that the procedure is effective."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Molecular Testing to Direct Extent of Initial Thyroid Surgery
Linwah Yip 2017. "Molecular Testing to Direct Extent of Initial Thyroid Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02947035.
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top